US5767310A
(en)
*
|
1993-03-19 |
1998-06-16 |
Merck & Co., Inc. |
Phenoxyphenylacetic acid derivatives
|
US5686478A
(en)
*
|
1993-07-20 |
1997-11-11 |
Merck & Co. Inc. |
Endothelin antagonists
|
US5767144A
(en)
*
|
1994-08-19 |
1998-06-16 |
Abbott Laboratories |
Endothelin antagonists
|
US7208517B1
(en)
|
1994-08-19 |
2007-04-24 |
Abbott Labortories |
Endothelin antagonists
|
US6162927A
(en)
*
|
1994-08-19 |
2000-12-19 |
Abbott Laboratories |
Endothelin antagonists
|
US5559135A
(en)
*
|
1994-09-14 |
1996-09-24 |
Merck & Co., Inc. |
Endothelin antagonists bearing pyridyl amides
|
US5538991A
(en)
*
|
1994-09-14 |
1996-07-23 |
Merck & Co., Inc. |
Endothelin antagonists bearing 5-membered heterocyclic amides
|
US5482960A
(en)
*
|
1994-11-14 |
1996-01-09 |
Warner-Lambert Company |
Nonpeptide endothelin antagonists
|
US5684032A
(en)
*
|
1994-12-13 |
1997-11-04 |
Smithkline Beecham Corporation |
Compounds
|
AU4514496A
(en)
*
|
1994-12-13 |
1996-07-03 |
Smithkline Beecham Corporation |
Novel compounds
|
DE19527568A1
(en)
*
|
1995-07-28 |
1997-01-30 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
DE19528418A1
(en)
*
|
1995-08-02 |
1997-02-06 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
FR2740773B1
(en)
*
|
1995-11-08 |
1997-12-19 |
Roussel Uclaf |
NOVEL IMIDAZOLE DERIVATIVES, PREPARATION PROCESS, INTERMEDIATES OBTAINED, APPLICATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE
|
DE19530032A1
(en)
*
|
1995-08-16 |
1997-02-20 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
DE19537548A1
(en)
*
|
1995-10-09 |
1997-04-10 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
FR2740774B1
(en)
*
|
1995-11-08 |
1997-12-19 |
Roussel Uclaf |
NOVEL IMIDAZOLE N-BENZYLDIOXOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NEW USE
|
DE19543639A1
(en)
*
|
1995-11-23 |
1997-05-28 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
EP1021181A4
(en)
*
|
1996-03-28 |
2002-06-26 |
Smithkline Beecham Corp |
Carboxylic acid indole inhibitors of chemokines
|
GB9609641D0
(en)
*
|
1996-05-09 |
1996-07-10 |
Pfizer Ltd |
Compounds useful in therapy
|
AU734841B2
(en)
|
1996-11-19 |
2001-06-21 |
Amgen, Inc. |
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
|
EP0988289A2
(en)
|
1997-06-05 |
2000-03-29 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds, their production and use
|
GB9716657D0
(en)
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902452D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902461D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
US6407101B1
(en)
|
1999-05-04 |
2002-06-18 |
American Home Products Corporation |
Cyanopyrroles
|
US6391907B1
(en)
|
1999-05-04 |
2002-05-21 |
American Home Products Corporation |
Indoline derivatives
|
US6417214B1
(en)
|
1999-05-04 |
2002-07-09 |
Wyeth |
3,3-substituted indoline derivatives
|
US6355648B1
(en)
|
1999-05-04 |
2002-03-12 |
American Home Products Corporation |
Thio-oxindole derivatives
|
US6423699B1
(en)
|
1999-05-04 |
2002-07-23 |
American Home Products Corporation |
Combination therapies using benzimidazolones
|
US6380178B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Cyclic regimens using cyclocarbamate and cyclic amide derivatives
|
US6319912B1
(en)
|
1999-05-04 |
2001-11-20 |
American Home Products Corporation |
Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
|
US6358947B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Tetracyclic progesterone receptor modulator compounds and methods
|
US6329416B1
(en)
|
1999-05-04 |
2001-12-11 |
American Home Products Corporation |
Combination regimens using 3,3-substituted indoline derivatives
|
US6399593B1
(en)
|
1999-05-04 |
2002-06-04 |
Wyeth |
Cyclic regimens using cyclic urea and cyclic amide derivatives
|
US6462032B1
(en)
|
1999-05-04 |
2002-10-08 |
Wyeth |
Cyclic regimens utilizing indoline derivatives
|
US6509334B1
(en)
|
1999-05-04 |
2003-01-21 |
American Home Products Corporation |
Cyclocarbamate derivatives as progesterone receptor modulators
|
US6306851B1
(en)
|
1999-05-04 |
2001-10-23 |
American Home Products Corporation |
Cyclocarbamate and cyclic amide derivatives
|
US6444668B1
(en)
|
1999-05-04 |
2002-09-03 |
Wyeth |
Combination regimens using progesterone receptor modulators
|
US6380235B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
US6339098B1
(en)
|
1999-05-04 |
2002-01-15 |
American Home Products Corporation |
2,1-benzisothiazoline 2,2-dioxides
|
US6369056B1
(en)
|
1999-05-04 |
2002-04-09 |
American Home Products Corporation |
Cyclic urea and cyclic amide derivatives
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
GB0000625D0
(en)
|
2000-01-13 |
2000-03-01 |
Zeneca Ltd |
Chemical compounds
|
UA73119C2
(en)
|
2000-04-19 |
2005-06-15 |
American Home Products Corpoir |
Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
|
GB0016162D0
(en)
*
|
2000-06-30 |
2000-08-23 |
Cancer Res Campaign Tech |
Indole-3-acetic acid derivatives
|
EP1305285B1
(en)
*
|
2000-07-25 |
2007-05-16 |
Merck & Co., Inc. |
N-substituted indoles useful in the treatment of diabetes
|
JP2004529855A
(en)
*
|
2000-10-10 |
2004-09-30 |
スミスクライン ビーチャム コーポレーション |
Substituted indoles, pharmaceutical compositions containing such substituted indoles and their use as PPAR-γ binders
|
ES2290318T3
(en)
|
2001-06-20 |
2008-02-16 |
Wyeth |
REPLACED DERIVATIVES OF INDOLIC ACID AS INHIBITORS OF THE INHIBITOR OF THE PLASMINOGEN-1 ACTIVATOR (PAI-1).
|
TWI224101B
(en)
|
2001-06-20 |
2004-11-21 |
Wyeth Corp |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
|
DE10147672A1
(en)
*
|
2001-09-27 |
2003-04-10 |
Bayer Ag |
Substituted 2,5-diamidoindoles and their use
|
US7713964B2
(en)
|
2001-12-03 |
2010-05-11 |
Wyeth Llc |
Methods for treating asthmatic conditions
|
US7605156B2
(en)
|
2001-12-03 |
2009-10-20 |
Wyeth |
Methods for the use of inhibitors of cytosolic phospholipase A2
|
DK1501826T3
(en)
|
2002-02-01 |
2007-01-29 |
Hoffmann La Roche |
Substituted indoles as alpha-1 agonists
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
ATE331709T1
(en)
|
2002-12-10 |
2006-07-15 |
Wyeth Corp |
SUBSTITUTED 3-CARBONYL-1-YL ACETIC ACID DERIVATIVES AS PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) INHIBITORS
|
UA80453C2
(en)
|
2002-12-10 |
2007-09-25 |
|
Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
BR0316584A
(en)
|
2002-12-10 |
2005-10-04 |
Wyeth Corp |
Substituted oxo-acetyl amino indole acetic acid derivatives as plasminogen activator inhibitor-1 inhibitors (parent-1)
|
ES2314289T3
(en)
|
2002-12-10 |
2009-03-16 |
Wyeth |
DERIVATIVES OF ACID 1H-INDOL-3-IL GLIOXILICO REPLACED WITH ARILO, ARILOXI AND ALQULOXI AS INHIBITORS OF THE PLASMINOGEN-1 ACTIVATOR INHIBITOR (PAI-1).
|
US7348351B2
(en)
|
2002-12-10 |
2008-03-25 |
Wyeth |
Substituted 3-alkyl and 3-arylalkyl 1H-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
|
US7141592B2
(en)
|
2003-09-25 |
2006-11-28 |
Wyeth |
Substituted oxadiazolidinediones
|
US7351726B2
(en)
|
2003-09-25 |
2008-04-01 |
Wyeth |
Substituted oxadiazolidinediones
|
US7446201B2
(en)
|
2003-09-25 |
2008-11-04 |
Wyeth |
Substituted heteroaryl benzofuran acids
|
US7163954B2
(en)
|
2003-09-25 |
2007-01-16 |
Wyeth |
Substituted naphthyl benzothiophene acids
|
US7268159B2
(en)
|
2003-09-25 |
2007-09-11 |
Wyeth |
Substituted indoles
|
US7265148B2
(en)
|
2003-09-25 |
2007-09-04 |
Wyeth |
Substituted pyrrole-indoles
|
US7582773B2
(en)
|
2003-09-25 |
2009-09-01 |
Wyeth |
Substituted phenyl indoles
|
US7332521B2
(en)
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
US7442805B2
(en)
|
2003-09-25 |
2008-10-28 |
Wyeth |
Substituted sulfonamide-indoles
|
US7420083B2
(en)
|
2003-09-25 |
2008-09-02 |
Wyeth |
Substituted aryloximes
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US7342039B2
(en)
|
2003-09-25 |
2008-03-11 |
Wyeth |
Substituted indole oximes
|
BRPI0512252A
(en)
|
2004-06-18 |
2008-02-19 |
Biolipox Ab |
compound or a pharmaceutically acceptable salt thereof, pharmaceutical formulation, use of a compound, method of treating a disease, combined product, and process for preparing a compound
|
RU2007106868A
(en)
|
2004-08-23 |
2008-09-27 |
Вайет (Us) |
Oxazole-naphthyl acids and their use as modulators of an inhibitor of plasminogen-1 (PAI) activator for the treatment of thrombosis and cardiovascular diseases
|
AU2005277137A1
(en)
|
2004-08-23 |
2006-03-02 |
Wyeth |
Pyrrolo-naphthyl acids as PAI-1 inhibitors
|
KR20070045353A
(en)
|
2004-08-23 |
2007-05-02 |
와이어쓰 |
Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
|
DE602005026867D1
(en)
|
2005-01-19 |
2011-04-21 |
Biolipox Ab |
INFLAMMATORY INDOL DERIVATIVES
|
GT200600228A
(en)
|
2005-05-27 |
2006-12-26 |
|
INHIBITORS OF PHOSPHOLIPASE A2 CITOSOLICA
|
EP1919866A2
(en)
|
2005-08-17 |
2008-05-14 |
Wyeth a Corporation of the State of Delaware |
Substituted indoles and use thereof
|
GB2431927B
(en)
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
BRPI0706523A2
(en)
|
2006-01-13 |
2011-01-04 |
Wyeth Corp |
compound of formula i; pharmaceutical composition; method of treating disorders that are related to or affected by inhibition of norepinephrine reuptake, the 5-ht6 receptor or the 5-ht2a receptor; a method of treating a learning disorder, a cognitive disorder, a memory disorder, a personality disorder, a behavioral disorder, a movement disorder, a neurodegenerative disorder, drug withdrawal disorder, sleep, an eating disorder, acute drug toxicity, a cardiovascular disorder, a sexual dysfunction, a gastrointestinal disorder, a genitourinary disorder, a pain disorder, a nervous disorder or a symptom disorder vasomotor; method of treating alzheimer's disease, attention deficit disorder, schizophrenia, parkinson's disease, tardive dyskinesia, ataxia, bradykinesia, paroxysmal dyskinesias, restless leg syndrome, tremor, essential tremor epilepsy, stroke or head trauma; method of treating coronary artery disease, myocardial infarction, transient ischemic attack, angina, atrial fibrillation, platelet aggregation, risk of blood clot formation, irritable bowel syndrome, chronic constipation, gastrointestinal reflux, dyspepsia, stress urinary incontinence or urge urinary incontinence; method of treating depression, obsessive compulsive disorder, suicidal tendency, anxiety disorder, bipolar disorder, panic disorder, nicotine withdrawal, alcohol withdrawal, cocaine withdrawal, heroin withdrawal, amphetamine withdrawal, narcotic drug withdrawal, insomnia, sleep apnea, narcolepsy, sanitary affective disorder, restless leg syndrome, work shift sleep disorder, delayed sleep syndrome, anorexia nervosa, bulimia nervosa, night eating syndrome, compulsive overeating, chronic fatigue syndrome, fibromyalgia, pain neuropathy, antinociceptive pain, chronic pain syndrome, diabetic neuropathy, hot flush or night sweat; and use of a compound
|
JP2009539881A
(en)
*
|
2006-06-09 |
2009-11-19 |
アイコス コーポレイション |
Substituted phenylacetic acid as a DP-2 antagonist
|
MX2009006878A
(en)
*
|
2006-12-22 |
2009-07-07 |
Schering Corp |
4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections.
|
AU2009325091A1
(en)
|
2008-05-23 |
2010-06-17 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein inhibitor
|
CN102321074B
(en)
*
|
2011-06-07 |
2013-04-10 |
山东轻工业学院 |
Indole ring-substituted pyrazole hydrazide derivative and preparation method and application thereof
|
TN2018000020A1
(en)
*
|
2015-07-20 |
2019-07-08 |
Genzyme Corp |
Colony stimulating factor-1 receptor (csf-1r) inhibitors.
|
JP2024500919A
(en)
|
2020-12-23 |
2024-01-10 |
ジェンザイム・コーポレーション |
Deuterated colony stimulating factor-1 receptor (CSF-1R) inhibitor
|